MENUNews Archive
Date: 03/27/2020
Antiandrogen treatment, however, is associated with heart and neurological problems and didn’t increase survival for men with low PSA levels, a University of Michigan study finds.
Date: 03/27/2020
More than 100 studies worldwide involving an abnormal modification in the tumor suppressor protein PP2A likely need a second look, research led by the University of Michigan Rogel Cancer Center has found. That’s because a new study suggests that commercially available antibodies used to investigate the modification aren’t fully reliable.
Date: 03/13/2020
We have temporarily revised our family and guest policy due to the coronavirus pandemic. Please click on the headline to learn more.
Date: 03/03/2020
The University of Michigan no longer has any teams competing in STAT Madness. The team led by Costas Lyssiotis, Ph.D. made it to Round 4. We are proud of the research done at the University of Michigan and are particularly proud for those who were recognized in this national competition.
Date: 02/27/2020
The multi-site phase Ib/II study looked at the combination of the immunotherapy drug pembrolizumab with bevacizumab for metastatic renal cell carcinoma. Pembrolizumab is known commercially as Keytruda and bevacizumab is known as Avastin.
Date: 02/26/2020
Globally, especially in low- and middle-income countries in Africa, Latin America, the Caribbean and Asia, an estimated 569,847 women were diagnosed with cervical cancer in 2018, with 85% of that burden occurring in low- and middle-income countries.
Date: 02/25/2020
MI-3454 resulted in complete remission in mouse models. Now, a Phase I clinical trial, using a structurally related analog of the compound, is currently enrolling patients.
Date: 02/11/2020
Women with early stage breast cancer who test positive for an inherited genetic variant aren’t always receiving cancer treatment that follows current guidelines, a new study finds.
Date: 01/29/2020
By studying two proteins, WDR5 and p53, researchers hoped to learn how -- or if -- these proteins could influence what stem cells developed into. WDR5 and p53 have long been studied in relation to cancer and this research also shed light on how WDR5 regulates p53 both directly and indirectly. For this reason, the research may also help illuminate an emerging class of anti-cancer drugs, WDR5 inhibitors.
Date: 01/20/2020
By continuously monitoring the body temperature of mice that had undergone bone-marrow transplants, researchers were able to detect early warning signs of graft-versus-host disease -- a dangerous, sometimes deadly response of the transplanted immune system -- in a simple, non-invasive way.